S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
NYSE:MDC

M.D.C. Stock Forecast, Price & News

$53.82
+0.03 (+0.06%)
(As of 12/8/2021 04:00 PM ET)
Add
Compare
Today's Range
$53.49
$54.46
50-Day Range
$46.29
$53.82
52-Week Range
$41.19
$63.86
Volume
392,301 shs
Average Volume
507,541 shs
Market Capitalization
$3.80 billion
P/E Ratio
7.05
Dividend Yield
3.72%
Beta
1.39
30 days | 90 days | 365 days | Advanced Chart
Receive MDC News and Ratings via Email

Sign-up to receive the latest news and ratings for M.D.C. and its competitors with MarketBeat's FREE daily newsletter.


M.D.C. logo

About M.D.C.

M.D.C. Holdings, Inc. provides homebuilding and financial services. Its homebuilding operations consist of wholly owned subsidiary companies that generally purchase finished lots or develop lots to the extent necessary for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the name Richmond American Homes. The company's financial services operations consist of mortgage loans, insurance coverage, re-insures Allegiant claims, third-party insurance products, and title agency services. M.D.C. Holdings was founded by Larry A. Mizel in 1972 and is headquartered in Denver, CO.

Headlines

Richmond American Completes First Home in Eagle
December 1, 2021 |  finance.yahoo.com
Richmond American Enters Austin Market
November 18, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry
Operative builders
Sub-Industry
Homebuilding
CUSIP
55267610
Employees
1,773
Year Founded
1972

Sales & Book Value

Annual Sales
$3.90 billion
Cash Flow
$5.98 per share
Book Value
$34.78 per share

Profitability

Net Income
$367.58 million
Pretax Margin
14.24%

Debt

Price-To-Earnings

Miscellaneous

Free Float
54,352,000
Market Cap
$3.80 billion
Optionable
Optionable

Company Calendar

Last Earnings
10/28/2021
Ex-Dividend
11/09/2021
Dividend Payable
11/24/2021
Today
12/09/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/01/2022

Social Links


MarketRank

Overall MarketRank

3.50 out of 5 stars

Construction Sector

1st out of 136 stocks

Operative Builders Industry

1st out of 20 stocks

Analyst Opinion: 3.1Community Rank: 3.7Dividend Strength: 3.3Insider Behavior: 4.2Valuation: 3.1 5 -4 -3 -2 -1 -












M.D.C. (NYSE:MDC) Frequently Asked Questions

Is M.D.C. a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for M.D.C. in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" M.D.C. stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDC, but not buy additional shares or sell existing shares.
View analyst ratings for M.D.C.
or view top-rated stocks.

How has M.D.C.'s stock been impacted by COVID-19?

M.D.C.'s stock was trading at $33.96 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MDC shares have increased by 58.5% and is now trading at $53.82.
View which stocks have been most impacted by COVID-19
.

When is M.D.C.'s next earnings date?

M.D.C. is scheduled to release its next quarterly earnings announcement on Tuesday, February 1st 2022.
View our earnings forecast for M.D.C.
.

How were M.D.C.'s earnings last quarter?

M.D.C. Holdings, Inc. (NYSE:MDC) released its quarterly earnings results on Thursday, October, 28th. The construction company reported $1.99 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $2.01 by $0.02. The construction company earned $1.26 billion during the quarter, compared to analysts' expectations of $1.36 billion. M.D.C. had a net margin of 11.14% and a trailing twelve-month return on equity of 24.48%. M.D.C.'s revenue for the quarter was up 25.7% compared to the same quarter last year. During the same quarter last year, the business posted $1.38 EPS.
View M.D.C.'s earnings history
.

How often does M.D.C. pay dividends? What is the dividend yield for M.D.C.?

M.D.C. declared a quarterly dividend on Friday, October 29th. Stockholders of record on Wednesday, November 10th will be paid a dividend of $0.50 per share on Wednesday, November 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 3.72%. The ex-dividend date is Tuesday, November 9th. This is an increase from M.D.C.'s previous quarterly dividend of $0.40.
View M.D.C.'s dividend history
.

Is M.D.C. a good dividend stock?

M.D.C. pays an annual dividend of $2.00 per share and currently has a dividend yield of 3.72%. M.D.C. has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio of M.D.C. is 26.19%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, M.D.C. will have a dividend payout ratio of 20.94% next year. This indicates that M.D.C. will be able to sustain or increase its dividend.
View M.D.C.'s dividend history.

What price target have analysts set for MDC?

4 analysts have issued 12-month price objectives for M.D.C.'s stock. Their forecasts range from $63.00 to $77.00. On average, they anticipate M.D.C.'s stock price to reach $67.75 in the next twelve months. This suggests a possible upside of 25.9% from the stock's current price.
View analysts' price targets for M.D.C.
or view top-rated stocks among Wall Street analysts.

Who are M.D.C.'s key executives?

M.D.C.'s management team includes the following people:
  • David D. Mandarich, President, Chief Executive Officer & Director
  • Robert Nathaniel Martin, Senior VP, Chief Financial & Accounting Officer
  • Michael Touff, Senior Vice President
  • Rebecca B. Givens, Senior Vice President & General Counsel
  • Joseph H. Fretz, Secretary, Vice President & Corporate Counsel

What other stocks do shareholders of M.D.C. own?

Based on aggregate information from My MarketBeat watchlists, some companies that other M.D.C. investors own include Alibaba Group (BABA), Verizon Communications (VZ), Procter & Gamble (PG), Intel (INTC), NVIDIA (NVDA), Cisco Systems (CSCO), Home Depot (HD), Johnson & Johnson (JNJ), Pfizer (PFE) and QUALCOMM (QCOM).

What is M.D.C.'s stock symbol?

M.D.C. trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDC."

Who are M.D.C.'s major shareholders?

M.D.C.'s stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (16.69%), Dimensional Fund Advisors LP (6.03%), Hamlin Capital Management LLC (2.30%), LSV Asset Management (1.87%), Geode Capital Management LLC (1.41%) and Bank of New York Mellon Corp (1.30%). Company insiders that own M.D.C. stock include David D Mandarich, David Siegel, Herbert T Buchwald, Larry A Mizel, Leslie B Fox, Michael A Berman, Paris G Reece III, Robert Nathaniel Martin and Staci M Woolsey.
View institutional ownership trends for M.D.C.
.

Which major investors are selling M.D.C. stock?

MDC stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Citigroup Inc., Invesco Ltd., Morgan Stanley, LSV Asset Management, Cubist Systematic Strategies LLC, Principal Financial Group Inc., and Goldman Sachs Group Inc.. Company insiders that have sold M.D.C. company stock in the last year include David Siegel, Herbert T Buchwald, Larry A Mizel, Leslie B Fox, Michael A Berman, Robert Nathaniel Martin, and Staci M Woolsey.
View insider buying and selling activity for M.D.C.
or view top insider-selling stocks.

Which major investors are buying M.D.C. stock?

MDC stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Raymond James & Associates, Miller Howard Investments Inc. NY, Hamlin Capital Management LLC, SG Americas Securities LLC, SkyOak Wealth LLC, Barclays PLC, and Strs Ohio.
View insider buying and selling activity for M.D.C.
or or view top insider-buying stocks.

How do I buy shares of M.D.C.?

Shares of MDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is M.D.C.'s stock price today?

One share of MDC stock can currently be purchased for approximately $53.82.

How much money does M.D.C. make?

M.D.C. has a market capitalization of $3.80 billion and generates $3.90 billion in revenue each year. The construction company earns $367.58 million in net income (profit) each year or $7.6378 on an earnings per share basis.

How many employees does M.D.C. have?

M.D.C. employs 1,773 workers across the globe.

When was M.D.C. founded?

M.D.C. was founded in 1972.

What is M.D.C.'s official website?

The official website for M.D.C. is www.mdcholdings.com.

Where are M.D.C.'s headquarters?

How can I contact M.D.C.?

M.D.C.'s mailing address is 4350 S MONACO STREET SUITE 500, DENVER CO, 80237. The construction company can be reached via phone at (303) 773-1100, via email at [email protected], or via fax at 303-771-3461.


This page was last updated on 12/9/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.